The company has discovered how its blockbuster diabetes drugs have become contaminated with a potential carcinogen and believes it can resolve the problem by the end of the year, Bloomberg News reported.
https://www.pharmalive.com/wp-content/uploads/2022/07/Merck-NYSE-Reuters.webp450675Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-01-17 13:15:092023-01-17 14:14:34Merck set to remove cancer-causing chemical from top diabetes drugs - Bloomberg News
